News Ayurcann Holdings Corp. OTC Markets

Equities

AYURF

CA05476A1012

Market Closed - OTC Markets Other stock markets 10:39:40 2024-06-13 am EDT			5-day change	1st Jan Change
0.0327 ^USD	-17.94%		+41.39%	+38.39%

May. 27	Ayurcann's Fiscal Q3 Loss Narrows on Higher Revenue	MT
May. 27	Ayurcann Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ayurcann's Fiscal Q3 Loss Narrows on Higher Revenue	May. 27	MT
Ayurcann Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 27	CI
AYURCANN REPORTS RECORD SALES IN Q3 2024 OF $11,655,360 FEATURING A 97% INCREASE IN GROSS REVENUE	May. 27	GL
Ayurcann Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 28	CI
AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE	Feb. 28	GL
Ayurcann Holdings to Expand Listings of Core SKUs, Completes Debt Settlement	Jan. 08	MT
Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs	Jan. 05	AQ
Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs	Jan. 05	GL
AYURCANN ANNOUNCES AGSM RESULTS	Dec. 22	AQ
AYURCANN ANNOUNCES AGSM RESULTS	Dec. 22	GL
Ayurcann Holdings Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 29	CI
AYURCANN REPORTS RECORD SALES IN Q1 2024 FEATURING A 249% INCREASE IN GROSS REVENUE	Nov. 29	GL
AYURCANN REPORTS 2023 FINANCIAL RESULTS FEATURING $22,371,604 IN GROSS REVENUE	23-10-30	GL
Ayurcann Holdings Corp. Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-29	CI
Ayurcann Holdings Corp. Provides Corporate Update	23-08-10	CI
AYURCANN HOLDINGS CORP. PROVIDES CORPORATE UPDATE, AND GROWTH STRATEGY	23-08-10	GL
Ayurcann Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-29	CI
AYURCANN REPORTS RECORD SALES OF $5,893,351 FOR Q3 2023, AN INCREASE OF 114% OVER Q3 2022	23-05-29	GL
AYURCANN REPORTS RECORD SALES OF $5,893,351 FOR Q3 2023, AN INCREASE OF 114% OVER Q3 2022	23-05-29	AQ
Ayurcann Holdings Corp.’s Equity Buyback announced on March 1, 2022, has expired.	23-02-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ayurcann Holdings Corp. OTC Markets

Equities

AYURF

CA05476A1012

Summary

Filters